葛月宾 刘芮 梅之南.基于肺脾气虚认识新型冠状病毒肺炎及诊疗方案中药的研究进展[J].中南民族大学学报自然科学版,2020,39(2):145-150
基于肺脾气虚认识新型冠状病毒肺炎及诊疗方案中药的研究进展
Traditional Chinese medicines for COVID-19 based on lung and spleen Qi deficiency syndrome
  
DOI:10.12130/znmdzk.20200207
中文关键词: 新型冠状病毒肺炎  肺脾气虚  中药
英文关键词: COVID-19  lung and spleen qi deficiency syndrome  traditional Chinese medicine
基金项目:湖北省科技厅新型肺炎应急科技攻关项目(2020FCA042);中央高校基本科研业务费专项资金资助项目(CZY19031)
作者单位
葛月宾 刘芮 梅之南 中南民族大学药学院民族药物研究院武汉430074 
摘要点击次数: 827
全文下载次数: 786
中文摘要:
      《新型冠状病毒肺炎诊疗方案》从试行第一版至第七版,均体现了中医药治疗的积极作用. 此次肺炎导致老年人群及基础疾病患者的发病率和致死率较高,这与此类人群体质状况息息相关. 从肺脾气虚角度认识新型冠状病毒肺炎的发生与发展,强调从轻症阶段开始应关注肺脾气虚病因,并宜早予以对证治疗;针对国家及省市区发布诊疗方案中高频次的六味补气健脾中药,进行成分、抗炎、抗氧化、调节免疫、靶点作用的研究现状综述,以期为临床医生合理使用和药物研发提供参考.
英文摘要:
      From the Diagnosis and Treatment of Novel Coronavirus Pneumonia Trail Version 1 to Version 7, traditional Chinese medicine has been playing the positive role in treating Corona Virus Disease 2019 (COVID-19). It is found that the older people or people with primary diseases are easily infected by the novel coronavirus with more high mortality, which is related to the special condition of them. Thus, the traditional medicinal theory of lung and spleen qi deficiency syndrome is applied to learn about the etiology of novel coronavirus pneumonia. Furthermore,six medicines in the Diagnosis and Treatment Version 7 are reviewed for chemical components, ant-inflammation, antioxidation, regulation of immunity and targeting action. It may provide a guide for clinicians to use and study the medicines.
查看全文   查看/发表评论  下载PDF阅读器
关闭